September kicked off with a red start as all three major indices closed lower, with combined trading volume barely holding above the 2 trillion yuan threshold. Market style rotated once again, with tech sectors like semiconductors and optics pulling back while consumption, agriculture, and financials took the lead. Geopolitical tensions combined with escalated expectations of a super El Ni帽o triggered a wave of limit-up moves in crop cultivation stocks, with the benchmark index tracking 农牧渔ETF华宝 (159275) climbing 2.4%.
As of last Friday, the Bloomberg Agriculture Spot Index, which tracks 10 major agricultural products, surged over 13% in August, marking its biggest monthly gain since July 2012. The banking sector presented a rare spectacle as Bank of China, China Construction Bank, ICBC, China CITIC Bank, Bank of Chengdu, Bank of Jiangsu, and Bank of Qingdao all hit new highs intraday. The benchmark index behind 银行ETF华宝 (512800), after rising 1.67% the previous day, added another 1.88% today to reach a seven-month high. Brokerage stocks strengthened in tandem, with Hualin Securities hitting the daily limit and the index underlying 券商ETF华宝 (512000) rising nearly 1% at one point. Digital currency concepts rallied, pushing the underlying index of 金融科技ETF华宝 (159851) up 1.88%.
Healthcare stocks across the A-share and Hong Kong markets remained active, with medical devices and CXO segments benefiting from strong earnings catalysts. The benchmark indices tracking both 医疗ETF华宝 (512170) and 港股通医疗ETF华宝 (159137) managed to buck the broader downturn.
Where to Focus for September Outlook
Looking ahead to September, China Securities Co., Ltd. (CSC) advises adopting a "rebalancing" approach to navigate the volatile market. Investors should maintain positions in sectors with continuously validated growth momentum, particularly AI computing hardware, non-ferrous metals, innovative drugs, and select export-oriented manufacturing with the highest earnings visibility. Simultaneously, allocating defensive positions as a baseline alongside low-valuation catch-up candidates can achieve a balanced portfolio structure that blends high growth with low volatility through dynamic rebalancing.
UBS, meanwhile, recently indicated in media commentary that now is an opportune time to re-enter technology stocks. The factors that previously triggered the tech pullback, including shifts in the AI narrative, concentrated positioning, and deleveraging, have largely been resolved. The firm advocates a barbell approach, favoring banks, non-ferrous metals, and export themes alike.
El Ni帽o Intensifies, Agriculture Sector Explodes Higher
The crop cultivation chain continued its aggressive advance today, with Shennong Seed Industry locking in a 20% limit-up by the close. Xinsai Shares, Longping High-Tech, Nongfa Seed Industry, Wanxiang Denong, Dunhuang Seed, Denghai Seed, and Jinjian Rice all hit limit-up, while Dabeinong and Beidahuang also posted strong gains. The CSI Agricultural, Livestock and Fishery Index, underlying 农牧渔ETF华宝 (159275), closed up 2.4%.
On the news front, the U.S. National Oceanic and Atmospheric Administration's (NOAA) Climate Prediction Center revised its forecast in August, raising the probability of a "very strong El Ni帽o" during October-December to 95%. The event is expected to peak around November-December and could become the strongest on record, potentially persisting through spring-summer 2027. The World Food Programme estimates that this El Ni帽o cycle could expand the number of people facing severe food insecurity across 45 key countries from approximately 225 million to 274 million by the end of 2027, adding at least 49 million affected individuals, with Central America and southern Africa hit hardest.
Guosen Securities notes that historically, super-strength El Ni帽o events are associated with elevated risks of regional droughts, floods, and heatwaves. Southeast Asia and India typically see reduced rainfall, while the west coast of South America and the southern United States experience increased precipitation. China may face anomalous weather patterns such as "flooding in the south and drought in the north," posing serious threats to global agricultural production. Additionally, ENSO cycles historically display quasi-periodic oscillations, with La Ni帽a typically following El Ni帽o, meaning disruptions to agricultural output could persist.
Orient Securities highlights that rising commodity prices have already transmitted to the agricultural sector. From a fundamental standpoint, the upward trend in grain prices is now established, with cultivation and seed industries showing improving fundamentals and presenting a compelling investment opportunity in large-scale farming. With heightened El Ni帽o intensity expectations, price upside for tropical cash crops such as natural rubber, sugar, and palm oil is likely to expand.
Valuation-wise, the agriculture, livestock, and fishery sector remains relatively low. Wind data shows that as of yesterday's close (August 31), the price-to-book ratio of the CSI Agricultural, Livestock and Fishery Index stood at 2.39 times, positioning it at the 18.43rd percentile of the past five years 鈥攁 low level that underscores its medium-to-long-term allocation appeal.
Looking forward, Huayuan Securities expects palm oil, sugar, cotton, and rubber to face more pronounced production cut risks during El Ni帽o years. The trend rise in crude oil prices is supporting the valuation floor of agricultural products through dual channels of "cost-push" and "demand-resonance." The firm recommends focusing on sugar, rubber, soybean meal, and related targets whose demand could be boosted by higher oil prices, alongside leading seed companies poised for profit recovery as grain prices rise.
For broad exposure to the agriculture-livestock-fishery value chain, 农牧渔ETF华宝 (159275) passively tracks the CSI Agricultural, Livestock and Fishery Index, which includes leading hog farming names alongside feed, grain cultivation, and animal health companies. Off-market investors can also access the sector via the feeder fund (Class A: 013471; Class C: 013472).
Banks Hit Mass Record Highs: What Signal Does It Send?
September opened hot for the banking sector, with Bank of China, China Construction Bank, ICBC, China CITIC Bank, Bank of Chengdu, Bank of Jiangsu, and Bank of Qingdao all logging record highs during intraday trading. Postal Savings Bank, Jiangyin Bank, Bank of Xi'an, and Minsheng Bank also posted solid gains. The index underlying 银行ETF华宝 (512800), after gaining 1.67% the previous session, advanced another 1.88% to mark a seven-month high since January 14, 2026.
Interim reports from listed banks released encouraging signals, with net interest margins posting their first quarter-over-quarter positive growth in over four years, driving continued recovery in earnings momentum. The six major state-owned banks collectively generated 2.004987 trillion yuan in operating revenue for the first half, with attributable net profits reaching 712.598 billion yuan, up nearly 30.1 billion yuan year-on-year.
Another highlight from the interim disclosures was the decision by major state-owned banks to uniformly raise their dividend payout ratios by 1 percentage point to 31%, marking the first such increase since 2015 and carrying notable symbolic weight. Data indicates the six largest banks plan interim dividend distributions totaling approximately 220.989 billion yuan, up 16.332 billion yuan or 7.98% from the prior year.
Policy tailwinds are also expected to generate new growth for banks. The Ministry of Housing and Urban-Rural Development, along with four other ministries, recently rolled out a package of real estate policy measures, including extending the maximum term for individual housing loans to 40 years, alongside supporting rules on disbursement, repayment methods, and risk controls. CITIC Securities believes these measures will help align real estate credit systems with the high-quality development model transformation, expecting incremental headroom for real estate-related loan growth and a high-confidence improvement outlook for asset quality.
Feng Chencheng, fund manager of 银行ETF华宝 (512800), attributes the near-term rally to low-valuation names benefiting from dividend increase narratives. Leading rural commercial banks currently trade at price-to-book ratios around 0.8-0.9x; given return-on-equity levels near 15%, valuation repair still has room. State-owned large banks, meanwhile, benefit from their bond-like allocation attributes. Looking ahead, Feng expects banking revenue to continue improving in the second half, while substantially reduced sell-side pressure, receding market risk appetite, and style rebalancing should support banks outperforming the broader market.
银行ETF华宝 (512800) and its feeder fund (Class A: 240019; Class C: 006697) passively track the CSI Banking Index, encompassing all 42 A-share listed banks. Its top ten heavyweight constituents include mega-caps such as China Merchants Bank, Agricultural Bank of China, and Bank of Communications, alongside growth-oriented joint-stock and regional lenders like Industrial Bank, Bank of Jiangsu, and SPD Bank, making it an efficient tool for capturing the banking sector's overall movement.
Medical Devices Inflect Higher While HK CXO Rides AI Momentum
Healthcare stocks across A-shares and Hong Kong defied the market downturn, with related products such as 医疗ETF华宝 (512170) and 港股通医疗ETF华宝 (159137) seeing renewed investor attention. A-share medical names showed mixed performance, though medical devices proved relatively resilient with Intco Medical leading gains at 4%, Mindray Medical rising 2.26%, and United Imaging advancing 1.15%, allowing 医疗ETF华宝 (512170) to close in positive territory. Hong Kong-listed healthcare names traded mostly lower, but heavyweight leaders including the WuXi group and GenScript Biotech provided firm support, lifting the underlying index of 港股通医疗ETF华宝 (159137) 0.73% to snap a four-session losing streak.
Interim earnings remain a critical market driver. In medical devices, Intco Medical posted double-digit growth in both revenue and net profit for the first half, Mindray's profit decline narrowed sharply to 5.4%, and United Imaging grew revenue 17% year-on-year. CSC research flags that the medical device industry has turned the corner on earnings recovery, with second-quarter 2026 attributable net profits recording their first positive growth in four years, signaling stabilization across the sector.
In Hong Kong-listed CXO, the three WuXi powerhouses (WuXi AppTec, WuXi Biologics, and WuXi XDC) all achieved double-digit revenue growth in the first half, with WuXi AppTec's semi-annual profit surpassing the 10 billion yuan milestone for the first time. GenScript grew revenue 27.3% on a normalized basis, with adjusted net profit reaching $62.52 million, up 203.3% year-on-year. Notably, AI for Science (AI4S) in the pharmaceutical field has the potential to translate into order growth across the entire CXO chain, further lifting overall sector valuation. China Post Securities points out that AI4S remains in a pre-breakthrough phase in drug discovery and could become the next strategic growth track.
For investors seeking exposure to the healthcare recovery, two key tools stand out: 港股通医疗ETF华宝 (159137) offers CXO content exceeding 50%, ranking first in the market, with the WuXi group accounting for over 38% of the portfolio. It also provides exposure to scarce leaders across innovative drugs, medical devices, internet healthcare, and AI pharma. The underlying assets are Hong Kong-listed, offering high beta and T+0 trading; the off-exchange feeder fund code is 026922. Meanwhile, 医疗ETF华宝 (512170), the flagship medical-pharma ETF with second-quarter assets of 25.624 billion yuan and average daily turnover of 670 million yuan since the year began, focuses on medical devices and services, featuring CXO content over 30% alongside brain-computer interface and AI healthcare themes. The off-exchange feeder fund code is 012323.
Sources: Shanghai and Shenzhen exchanges, etc., as of September 1, 2026. Institutional views cited from: 1) CSC, August 30, 2026, "Rebalancing to Navigate Rangebound Markets"; 2) Huayuan Securities, August 25, 2026, "Demand Improving at the Margin; Hog Prices Rising Gradually"; 3) Orient Securities, August 23, 2026, "Supply Disruption Expectations Strengthening; Agricultural Products Trending Higher"; 4) Guosen Securities, August 31, 2026, "Agricultural Products Special Report: Current El Ni帽o Could Set Records, Potentially Catalyzing a New Agricultural Price Cycle"; 5) CITIC Securities, August 26, 2026, "Banking | Value Re-rating of Large Banks in a Global Context"; 6) CSC, August 30, 2026, "Medical Devices 2026 Interim Summary: Quarterly Earnings Improving Markedly; Focus on Long-term Opportunities"; 7) China Post Securities, August 27, 2026, "AI4S (II): Before the Drug Discovery Breakthrough: New Paradigms Forming, Molecular Validation Demand Rising."
Risk Disclosure: 农牧渔ETF华宝 (159275) passively tracks the CSI Agricultural, Livestock and Fishery Index, with a base date of December 31, 2004, and a launch date of December 12, 2016. 银行ETF华宝 (512800) passively tracks the CSI Banking Index, base date December 31, 2004, launched July 15, 2013; index annual gains for 2021-2025 were: 6.79%, 34.71%, -7.27%, -8.78%, and -4.41%, with five-year annualized volatility of 14.03%, 19.34%, 13.41%, 18.56%, and 18.63%. 医疗ETF华宝 and its feeder fund passively track the CSI Healthcare Index, base date December 31, 2004, launched October 31, 2014; index annual returns/annualized volatility for 2021-2025 were: -14.71%/34.42%, -25.10%/29.45%, -24.25%/18.63%, -17.16%/36.02%, and 3.08%/19.73%. 港股通医疗ETF华宝 and its feeder fund passively track the CSI Hong Kong Stock Connect Healthcare Thematic Index, base date December 31, 2018, launched July 21, 2022; index annual returns/annualized volatility for 2021-2025 were: -28.26%/38.74%, -15.99%/46.88%, -32.92%/32.96%, -25.08%/44.18%, and 48.20%/32.72%. Index constituent compositions adjust according to index rules; historical back-tested performance does not predict future index behavior. Stocks mentioned are objective index constituents for demonstration only and do not constitute recommendations or reflect fund manager or fund investment directions. Any information appearing herein (including but not limited to stocks, commentary, forecasts, charts, indicators, theories, or any form of expression) serves as reference only; investors bear sole responsibility for their own investment decisions. Furthermore, any views, analysis, or forecasts herein do not constitute investment advice to readers, and the company assumes no liability for direct or indirect losses arising from use of this content. Investors should carefully read fund legal documents including the Fund Contract, Prospectus, and Fund Product Information Summary to understand risk-return characteristics and select products suited to their risk tolerance. Past performance does not indicate future results, and performance of other funds managed by the fund manager does not guarantee the performance of this fund. Per fund manager assessment, 农牧渔ETF华宝 (159275), 银行ETF华宝 (512800), and 医疗ETF华宝 (512170) carry risk rating R3-medium risk, suitable for balanced (C3) and above investors; 港股通医疗ETF华宝 and feeder funds carry R4-medium-high risk, suitable for aggressive (C4) and above investors; suitability matching opinions should follow sales institution guidance. Sales institutions (including manager direct sales and other distributors) assess fund risk according to applicable regulations; investors should monitor manager suitability opinions, as distributor opinions may differ, and distributor risk ratings shall not be lower than manager assessments. Fund contract risk-return profiles may differ from risk ratings due to varying considerations. Investors should understand fund risk-return situations, carefully select products aligned with their investment objectives, timeframes, experience, and risk tolerance, bearing risks themselves. CSRC registration of these funds does not constitute a substantive judgment or guarantee of investment value, market prospects, or returns. Fund investment requires caution.